Confirmed participants include #PhilippeAghion, @s-stantcheva.bsky.social, @johnvanreenen.bsky.social; @heidiwilliams.bsky.social will lead an illustrious policy panel discussing how research is used in govt fiscal analysis.

Conference on 19-20 Mar; submission deadline 30 Nov. Mark your calendars!

📢 Conference announcement!

Paolo Surico and I are excited to be organizing this @cepr.org conference on Public Policies for Innovation.

If you work in the #Economics of #Innovation and #InnovationPolicy, please submit + spread the word. Non-presenting attendees also invited.

Proud to have worked with this crew, especially Justin Walthier and Hana Ryan, who are both legal prodigies. Thanks to @prmalone.bsky.social, Nina Srejovic, and @stanfordlaw.bsky.social for support, and to @patentscholar.bsky.social for making this happen. We hope the court finds the brief helpful.

Tagging @fgaessler.bsky.social. I remember this paper from its early days - happy to see this out! Congrats

Also find it hard to believe a complex paper like this was made up from whole cloth... but could be wrong. Retraction + expulsion clearly points to major misconduct of some kind. I prefer facts over speculation--we'll get them eventually. For now the key thing to do is just to stop citing the paper!

This is a thoughtful take worth a full read. Despite all the hot takes I find it hard to have a point of view over the specific faults or appropriate remedies (individual to the author, or systemic) until we know more about what happened.

Good news is that next time we can have GPT adjudicate. Happy to submit to binding AI arbitration. 🤖

^ This guy gets it (in my impartial opinion)

Fantastic thread on an important paper. Andrew's previous paper ("The Returns to Government R&D: Evidence from U.S. Appropriations Shocks") also worth a read.

Reviewing the history of US indirect cost recovery policy, presenting new data on indirect cost recovery rates, modeling the effects of a 15 percent cap at the NIH, and evaluating tradeoffs across reform options, from Azoulay, Gross, and Sampat https://www.nber.org/papers/w33627

Tariffs get all the attention, but ask economists what they're really worried about and many will point to the Trump administration's cuts to federal support for the sciences, including canceling grants and revoking student visas.
#EconSky
www.nytimes.com/2025/03/31/b...

Slightly less poetically perhaps. You're dating yourself w Joni Mitchell instead of the Counting Crows... Meanwhile everyone younger than us is wondering both who and what are those 🤷

Looks like the cat is out of the bag. Good post by @stuartbuck.bsky.social on indirect cost recovery citing new joint work with @sampat.bsky.social and @pierre-azoulay.bsky.social.

Find it here: www.dropbox.com/scl/fi/g8792...

@danielpgross.bsky.social & @sampat.bsky.social introduce a comprehensive, open-access #dataset identifying US government-funded patents from 1900-2020. The government's share of patented innovations reached its zenith during WWII - comprising 11% of all US filings.
cepr.org/voxeu/column...
#EconSky

The US WW2 medical research and development effort catalyzed postwar science, modernized drug discovery, and fueled the postwar National Institutes of Health — reshaping biomedical innovation for decades, from Daniel P. Gross and Bhaven N. Sampat https://www.nber.org/papers/w33457

I have been studying bureaucracy my entire career. Here are some insights from my research about the ongoing efforts to transform the US federal bureaucracy newsroom.haas.berkeley.edu/is-the-u-s-c...

Woot!!! Amazing to hear it's official. A huge win for everyone at Duke.

A good summary of what's gone on with NSF funding, and some interesting new tidbits.

I'm really pleased they chose to end with @wytham88.bsky.social and a link to our paper:
“Grants don’t just generate knowledge or output now, they’ve become a way that we support the training of future scientists.”

Full thread coming soon. If you want a break from current events, come see the talk at the Virtual Seminar on Innovation and Economic Growth this Wednesday 12pm ET! sites.google.com/view/v-s-inn...

Kudos to Alex and Murat for creating a new seminar 💪

Perhaps the last (but not least) WW2-related paper I'll write w/ @sampat.bsky.social

#Econsky
@scientificdiscovery.dev
@dkthomp.bsky.social
@alecstapp.bsky.social
@calebwatney.bsky.social
@jamespethokoukis.bsky.social
@heidiwilliams.bsky.social
@pierre-azoulay.bsky.social

Paper highlights the potential long-run impacts of integrated, cross-sectoral biomed. R&D policy focused on solving problems--complementing traditional NIH approach of funding undirected science. Echoes in the Covid era, which may have heralded a new golden age: www.nytimes.com/2023/06/23/m...

Full thread coming soon. If you want a break from current events, come see the talk at the Virtual Seminar on Innovation and Economic Growth this Wednesday 12pm ET! sites.google.com/view/v-s-inn...

Kudos to Alex and Murat for creating a new seminar 💪

🔊🔊New WP: "The Therapeutic Consequences of the War: World War II and the 20th-Century Expansion of Biomedicine"

How WW2 transformed biomed. science, triggered a golden age of drug discovery, and fueled the postwar NIH. Insights for biomed R&D today. 💉

Link: www.dropbox.com/scl/fi/fuhc8...

It's such a weird thing to hear the news and think "that's bad, but also I have a paper about (an aspect) of that"

Funding delays are really not great for people who work in science. Funding delays of > 30 days lead to:

- 40% increase in scientists exiting US labor force
- 20% decrease in wages